Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01324427 · ClinicalTrials.gov registry record · NA

Telemedicine Evaluation for Stem Cell Transplant Patients

A NA study of Stem Cell Transplant Patients, sponsored by Memorial Sloan Kettering Cancer Center.

Completed
Registry status
NA
Development phase
43
Enrollment target
4
Study locations

NCT01324427 is a NA study of Stem Cell Transplant Patients that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 43 participants. The trial reports 4 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01324427, a NA study of Stem Cell Transplant Patients, has completed, sponsored by Memorial Sloan Kettering Cancer Center.

COMPLETED
Registry status
NA
Development phase
43 participants
Enrollment target
4
Study locations

Study Summary

Telemedicine is a new area of health care where medical information is transferred through audiovisual media, such as a computer or a video camera, for the purpose of remote doctor's visits or examinations. This new area of health care is important to test because it can potentially provide real-time interactions between the patient and their health care team, including phone conversations, online communication, and/or home visits. Many activities such as a history review or physical examination can be conducted virtually as compared to the traditional face-to face visits. The purpose of this study is to determine patient and health care team acceptance of a "virtual medical visit" as a substitute for a "face to face" visit for patients either preparing to receive a stem cell transplant or previously received a stem cell transplant.

Interventions

  • BEHAVIORAL virtual medical visit

Study Locations (4)

New York

  • Memorial Sloan-Kettering Cancer Center @ Suffolk - Commack
  • Memorial Sloan Kettering Cancer Center - New York
  • Memorial Sloan-Kettering Cancer Center at Phelps Memorial Hospital Center - Sleepy Hollow

New Jersey

  • Memoral Sloan Kettering Cancer Center - Basking Ridge

Trial Details

FieldValue
Enrollment Target 43 participants
Start Date 2011-03
Est. Completion 2020-08
Phase NA

Sponsor

Memorial Sloan Kettering Cancer Center

1,884 total trials

What the Registry Record Tells You About NCT01324427

The ClinicalTrials.gov registry entry for NCT01324427 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stem Cell Transplant Patients appearing as the primary indexed condition, and to 1 intervention - of which virtual medical visit is the first listed.

NCT01324427 reports 4 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.

Frequently Asked Questions

What is clinical trial NCT01324427 about?

NCT01324427 is a clinical study titled "Telemedicine Evaluation for Stem Cell Transplant Patients". Telemedicine is a new area of health care where medical information is transferred through audiovisual media, such as a computer or a video camera, for the purpose of remote doctor's visits or examinations. This new area of health care is important to test because it can potentially provide real-tim...

What is the current status of trial NCT01324427?

This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2011-03. Estimated completion is 2020-08.

What conditions does trial NCT01324427 study?

This clinical trial studies the following conditions: Stem Cell Transplant Patients.

What interventions are being tested in trial NCT01324427?

The interventions under investigation include: virtual medical visit (BEHAVIORAL).

Who is sponsoring clinical trial NCT01324427?

This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01324427 being conducted?

This trial has 4 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.